Real-world treatment patterns and clinical outcomes for patients with relapsed/refractory multiple myeloma who received elranatamab

05/01/2026
01/07/2026
EU PAS number:
EUPAS1000000852
Study
Ongoing
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

C1071050_Protocol_v1.0_Pfizer-Flatiron_16-Dec-2025_Redacted.pdf

English (1.88 MB - PDF) View document
Updated protocol

C1071050_Protocol_v2.0_22May2026_Redacted.pdf

First published: 30/06/2026
English (744.8 KB - PDF) View document
Study results
Study report
Other information